WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 1'2401 Infant (under 12 months) mortality rate: 392
GDP / capita (US$): 2'7801 Child (under 5 years) mortality rate: 452

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 8'735  8'549  8'363  8'178  7'995  6'216  5'284  3'905 
Births 252  251  249  246  241  188  212  160 
Surviving infants 243  242  239  236  232  175  192  142 
Pop. less than 5 years 1'183  1'165  1'145  1'125  1'099  892  939  633 
Pop. less than 15 years 3'072  3'002  2'938  2'882  2'833  2'643  2'315  1'671 
Female 15-49 years 2'263  2'228  2'191  2'150  2'107  1'516  1'173  879 

Number of reported cases

(Click for retrospective incidence data for Tajikistan)
Diphtheria
ChartChart
  11  11 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  52  16  192  6'897 
Mumps
ChartChart
  1'790  1'530  1'518  428 
Pertussis
ChartChart
  13  935 
Polio*
ChartChart
 
Rubella
ChartChart
  111 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Tajikistan)
Vaccine year result method % card seen                                                
BCG 2011  98  DHS   91  98  98  98  98  97  99 
DTP1 2011  98  DHS   91  98  97  99  98  96  98 
DTP3 2011  93  DHS   91  96  96  97  96  94  96 
DTP4          96  92  96 
IPV1         
HepB_BD          92  95  98  98  98 
HepB3 2011  93  DHS   91  97  96  97  96  94 
Hib3 2011  93  DHS   91  97  96  97  96  94 
JapEnc         
MCV1          97  97  98  92  95  98 
MCV2          97  94  98  92  97  31 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2011  92  DHS   91  97  96  94  97  96  98 
Rota1          97  94 
RotaC          96  85 
RCV1          97  97  98  92 
TT2plus          97 
PAB         
VAD1          99  99  97 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Tajikistan)
BCG
ChartChart
  98  98  98  98  97  98 
DTP1
ChartChart
  98  97  98  98  96  88 
DTP3
ChartChart
  96  96  97  96  94  83 
HepB3
ChartChart
  97  96  97  96  94 
HepB_BD
ChartChart
  92  95  98  98  98 
Hib3
ChartChart
  97  96  97  96  94 
IPV1
 
MCV1
ChartChart
  97  97  98  92  94  88 
MCV2
ChartChart
  97  94  98  92  97  59 
PCV3
 
Pol3
ChartChart
  97  96  94  97  96  86 
RCV1
ChartChart
  97  97  98  92  94 
RotaC
ChartChart
  96  85 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 66  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 98
From 80 to 89% 2
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 2-5 days; 6, 16 years; Yes
DT 6 year; Yes
DTwP 16 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB_Pediatric birth; Yes
IPV 4 months; Yes From September 2017
MR 12 months, 6 years; Yes
OPV birth; 2, 3, 4, 12 months; Yes
Rotavirus 2, 3 months; Yes
Td 16, 26, 36, 46, 56 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2016-2020  2011-2015  2010-2015  2010-2015  2011-2015  2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 66  66  66  65 

System performance

Total Nº districts in country number 66  66  65  66  66  66  65 
Nº districts with DTP3 coverage >=80% number 66  66  65  66  66  66  65 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 64  58  65  60  59  59  46 
% of districts with MCV1 coverage >=95% From 0 to 100% 97  88  100  91  89  89  71 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 23  28  31    22  34  41 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.